These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Lin HJ; Lo WC; Cheng YC; Perng CL Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286 [TBL] [Abstract][Full Text] [Related]
11. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study. Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361 [TBL] [Abstract][Full Text] [Related]
13. Treatment of peptic ulcer severe bleeding. Vandermeeren A; Bourgeois N; Buset M; Delhaye M; Deviere J; Desmarez B; Gay F; Van Gossum A; Cremer M Acta Gastroenterol Belg; 1992; 55(3):271-84. PubMed ID: 1632144 [TBL] [Abstract][Full Text] [Related]
14. Role of proton pump inhibitors in the management of peptic ulcer bleeding. Lin HJ World J Gastrointest Pharmacol Ther; 2010 Apr; 1(2):51-3. PubMed ID: 21577296 [TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420 [TBL] [Abstract][Full Text] [Related]
16. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Schaffalitzky de Muckadell OB; Havelund T; Harling H; Boesby S; Snel P; Vreeburg EM; Eriksson S; Fernström P; Hasselgren G Scand J Gastroenterol; 1997 Apr; 32(4):320-7. PubMed ID: 9140153 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata. Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754 [TBL] [Abstract][Full Text] [Related]
18. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial. Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964 [TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding. Chan WH; Khin LW; Chung YF; Goh YC; Ong HS; Wong WK Br J Surg; 2011 May; 98(5):640-4. PubMed ID: 21305536 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer. Yamada S; Wongwanakul P J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]